Bora Pharmaceuticals Co., LTD.

TWSE:6472 Stock Report

Market Cap: NT$77.4b

Bora Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Bobby Sheng

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure9.8yrs
CEO ownership6.8%
Management average tenure6.7yrs
Board average tenure8yrs

Recent management updates

Recent updates

Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Apr 10
Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Apr 08
Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Mar 14
Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Apr 30
Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Mar 17
Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

Feb 17
Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Jan 27
New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

Jan 19
Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Dec 29
We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

Dec 09
Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

CEO

Bobby Sheng

9.8yrs

Tenure

Mr. Pao-Shi Sheng, also known as Bobby, serves as Chairman of the Board at SunWay Biotech Co. LTD. since 2024. He Founder of Earth 88 and serves as its Chief Executive Officer.He serves as an Independent...


Leadership Team

NamePositionTenureCompensationOwnership
Pao-Shi Sheng
Chairmanno datano data6.82%
NT$ 5.3b
Alice Wang
CFO of HQ & APAC11.3yrsno datano data
Ellen Chen
Corporate Human Resource Director2.3yrsno datano data
Shih-Min Chen
VP & Director11.1yrsno data1.1%
NT$ 851.3m
Sally Langa
Senior VP of Marketing and Sales - CDMO Businessno datano datano data
Marcel Vieno
CFO of North Americano datano datano data
Tom Chang
Senior Vice President of Taiwan Site Operations1.3yrsno datano data
Xiu-Rong Zhang
Deputy General Managerno datano data0.010%
NT$ 7.8m
Zhen-Tang Zhang
Deputy General Managerno datano data0.097%
NT$ 74.8m

6.7yrs

Average Tenure

Experienced Management: 6472's management team is seasoned and experienced (6.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Pao-Shi Sheng
Chairman9.8yrsno data6.82%
NT$ 5.3b
Shih-Min Chen
VP & Director9.8yrsno data1.1%
NT$ 851.3m
Jui-Yi Lin
Independent Director9.1yrsno datano data
Shang-Hung Shen
Director9.8yrsno datano data
Kuan-Pai Chen
Director4.9yrsno datano data
Ming-Jung Lai
Independent Director6.9yrsno datano data
Yi-Chin Lee
Independent Director6.9yrsno data0.032%
NT$ 24.8m
Hsin-I Lin
Independent Directorless than a yearno data0.00099%
NT$ 766.5k

8.0yrs

Average Tenure

Experienced Board: 6472's board of directors are considered experienced (8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.